Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
Related Posts
Trump Budget Cuts Funding for CDC
Kennedy has warned of an epidemic of chronic disease, but the budget blueprint would close the C.D.C. center focused on…
Trump Administration Proposes Sharp Budget Cuts for H.H.S.
An internal memo proposes carving out $40 billion from federal health agencies while eliminating dozens of programs. Congress has ultimate…
Boar’s Head Shuts Down Virginia Plant Tied to Deadly Listeria Outbreak
The company said that the site would close indefinitely and that it would permanently stop making liverwurst. Union officials said…